Dual Chamber Leadless Pacemaker: Child First in World – Pioneering Implantation

Leadless Pacemakers for Children: A New Era in Pediatric Heart Care

Are you a parent concerned about congenital heart block or⁤ a healthcare professional seeking the latest advancements in pediatric cardiac pacing? The landscape of pediatric cardiology is rapidly evolving, and a groundbreaking new procedure is offering hope and‍ freedom too ‍young patients. For the first‍ time‍ ever, a dual-chamber leadless pacemaker has been successfully ‍implanted in a child, marking a critically important leap forward in treatment options. ⁢This‍ article delves into the details of this revolutionary procedure, its benefits, and what it means for ⁤the future of pediatric heart care.

A World First at UC Davis Health

Dr.Dan ‍Cortez, Director of‍ Pediatric Electrophysiology at UC Davis health, has⁢ once again pushed the boundaries⁤ of medical innovation. He recently achieved a world first: the ⁤successful ⁢implantation of an AVEIR dual-chamber leadless pacemaker in a 13-year-old patient. This landmark case,⁤ detailed in a recent publication in PACE: Pacing and Clinical Electrophysiology [https://www.wiley.com/en-us/PACE-Pacing-and-Clinical-Electrophysiology-p-9781119729844], represents a paradigm shift in how congenital complete heart block is managed in children.

Understanding Congenital Complete Heart Block

Congenital complete⁤ heart block (CCHB) is a rare but serious condition affecting approximately 1 in 15,000 to 22,000⁢ newborns [https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.036649]. It occurs when the electrical signals that coordinate heartbeats are fully blocked, leading to a dangerously slow heart rate.This can cause symptoms like presyncope (feeling faint or dizzy),⁤ fatigue, and, in severe cases,⁤ sudden cardiac arrest.CCHB can arise ⁢from several factors:

repaired Congenital Heart Disease: Sometimes, it’s a consequence of correcting other heart defects.
Genetic Predisposition: ‍ Certain ⁣genetic⁢ factors can increase the risk.
Maternal Antibodies: Exposure⁤ to specific maternal antibodies during pregnancy can disrupt the‍ fetal⁢ heart’s electrical system.Traditionally, pacemakers have ‍been the ⁤standard treatment for⁢ CCHB, ensuring a consistent and adequate heart rate. However, traditional pacemakers come with⁢ potential complications ⁣related to the leads – the wires that connect the device to the heart.

The Limitations of Traditional Pacemakers

Traditional pacemakers, while life-saving, aren’t without their drawbacks. Lead-related complications, such as infection, dislodgement, and fracture, can occur, possibly requiring further interventions.Thes concerns are particularly relevant for active children and adolescents. Furthermore, the size and placement⁢ of traditional pacemakers can⁣ sometimes restrict certain⁣ physical activities.

Enter Leadless Pacemakers: A Game Changer

Leadless pacemakers, as the name suggests, eliminate the need for leads. ⁢These tiny devices are implanted directly into the heart chamber and deliver electrical ‍impulses to regulate the heartbeat. The AVEIR dual-chamber leadless pacemaker, recently approved by the FDA in‍ 2023 [https://news.abbott.com/newsroom/company/abbott-receives-fda-approval-for-aveir-dual-chamber-leadless-pacemaker/default.aspx], takes this technology a step further by simultaneously pacing both the atrium ⁢and ventricle – mimicking the natural coordination of the heart.

Why This Implantation is ⁤Different

Dr. Cortez’s innovative approach involved implanting the AVEIR device via⁢ the right internal jugular vein, rather ⁣than the more ‍commonly used femoral vein. This⁢ technique allows for quicker recovery and a faster return to normal activities, including sports. ⁤ The AVEIR device itself is a marvel of engineering:

Size: Approximately 10 times smaller than traditional pacemakers.
Absorption: Designed to be absorbed by ⁢the heart tissue over time.
minimally Invasive: Implanted through a small incision, minimizing trauma.

The patient’s Success ‍Story

The 13-year-old patient who received the AVEIR pacemaker experienced no complications during ⁣or after the procedure. ⁣ Within three months, they ⁣were able to fully resume exercise and participate in sports without restrictions – a life-changing outcome.

Dr. ⁢Cortez: A Pioneer in Pediatric Leadless Pacing

This latest achievement builds upon Dr.Cortez’s extraordinary track record. He was the first ‍physician globally to:

2023: Implant a‍ retrievable ⁣leadless pacemaker in‍ a child.
2018: ‍ Implant a Micra single-chamber lead

Leave a Comment